Prevalence and burden of difficult‐to‐treat and severe asthma in Australia: A national population survey
Respirology · 2024-08 · 29 (8) · 685-693
DOI: 10.1111/resp.14722 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respirology, online erschienen am 06.05.2024. Verfasst von Sharon R Davis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Australian Centre for Airways disease Monitoring, The Woolcock Institute of Medical Research, Macquarie University, Sydney, New South Wales, Australi…. Hauptthemen laut MEDLINE: Asthma, COVID-19, Quality of Life. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Perpetual Philanthropy, AstraZeneca Australia, GlaxoSmithKline Australia.
Abstract (Originalsprache)
Background and Objective Most evidence about difficult‐to‐treat and severe asthma (DTTA) comes from clinical trials and registries. We aimed to identify people with DTTA from a large nationally representative asthma population and describe their characteristics and healthcare utilization compared with people whose asthma was not ‘difficult‐to‐treat’.
Methods
We conducted a cross‐sectional survey of Australians aged ≥18 years with current asthma from large web‐based survey panels. Enrolment was stratified by gender, age‐group and state/territory based on national population data for people with asthma. Difficult‐to‐treat or severe asthma was defined by poor symptom control, exacerbations and/or oral corticosteroid/biologic use despite medium/high‐dose inhaled therapy. Outcomes included exacerbations, healthcare utilization, multimorbidity, quality of life and coronavirus disease of 2019 (COVID‐19)‐related behaviour. Weighted data were analysed using SAS version 9.4.
Results
The survey was conducted in February–March 2021. The weighted sample comprised 6048 adults with current asthma (average age 47.3 ± SD 18.1 years, 59.9% female), with 1313 (21.7%) satisfying ≥1 DTTA criteria. Of these, 50.4% had very poorly controlled symptoms (Asthma Control Test ≤15), 36.2% were current smokers, and 85.4% had ≥1 additional chronic condition, most commonly anxiety/depression. More than twice as many participants with DTTA versus non‐DTTA had ≥1 urgent general practitioner (GP) visit (61.4% vs. 27.5%, OR 4.8 [4.2–5.5, p < 0.0001]), or ≥1 emergency room visit (41.9% vs. 17.9%, OR 3.8 [3.3–4.4, p < 0.0001]) in the previous 12 months.
Conclusion
Our findings emphasize the burden of uncontrolled symptoms, current smoking, multimorbidity and healthcare utilization in people with DTTA in the community, who may be under‐represented in registries or clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Australian Centre for Airways disease Monitoring, The Woolcock Institute of Medical Research, Macquarie University, Sydney, New South Wales, Australia.
- Ulsan University Hospital, Ulsan, Korea.
- School of Clinical Medicine, University of NSW, Sydney, New South Wales, Australia.
- Sydney Local Health District, Sydney, New South Wales, Australia.
- Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
- Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
ORCID-Profile: Sharon R Davis, Leanne M Poulos, Guy B Marks, Brett G Toelle, Helen K Reddel
Förderung
- Perpetual Philanthropy
- AstraZeneca Australia
- GlaxoSmithKline Australia
- National Health and Medical Research Council
- Novartis
Zitieren
APA
Davis, S. R., Ampon, R. D., Poulos, L. M., Lee, T., Marks, G. B., Toelle, B. G., & Reddel, H. K. (2024). Prevalence and burden of difficult‐to‐treat and severe asthma in Australia: A national population survey. Respirology, 29(8), 685-693. https://doi.org/10.1111/resp.14722
Vancouver
Davis SR, Ampon RD, Poulos LM, Lee T, Marks GB, Toelle BG, et al. Prevalence and burden of difficult‐to‐treat and severe asthma in Australia: A national population survey. Respirology. 2024;29(8):685-693. doi:10.1111/resp.14722
BibTeX
@article{Davis2024,
author = {Davis, Sharon R and Ampon, Rosario D and Poulos, Leanne M and Lee, Taehoon and Marks, Guy B and Toelle, Brett G and Reddel, Helen K},
title = {Prevalence and burden of difficult‐to‐treat and severe asthma in Australia: A national population survey},
journal = {Respirology},
year = {2024},
volume = {29},
number = {8},
pages = {685--693},
doi = {10.1111/resp.14722}
}
EUVIMED